Abstract
A Phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors: Saltz L, Kemeny N, Schwartz G, Kelsen D. Memorial Sloan-Kettering Cancer Ctr., 1275 York Avenue, New York, NY 10021. Cancer 1994;74;Suppl: 958–961
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
